Empyrean Capital Partners, LP - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Empyrean Capital Partners, LP ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$11,696,959
+14.5%
13,500,000
+12.5%
0.72%
+55.9%
Q2 2023$10,215,000
+14.6%
12,000,000
+14.3%
0.46%
+51.3%
Q1 2023$8,912,400
+2.1%
10,500,0000.0%0.31%
+11.3%
Q4 2022$8,728,125
+4.3%
10,500,0000.0%0.28%
+5.8%
Q3 2022$8,372,000
+24.3%
10,500,000
+23.5%
0.26%
+21.5%
Q2 2022$6,736,0008,500,0000.21%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders